NON-SMALL CELL LUNG CANCER (STAGE III)
Clinical trials for NON-SMALL CELL LUNG CANCER (STAGE III) explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER (STAGE III) trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER (STAGE III), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo attack on early lung cancer shows promise
Disease control OngoingThis study is testing whether adding an immunotherapy drug called durvalumab to a precise form of radiation therapy (SBRT) works better than radiation alone for early-stage lung cancer. It is for patients with a higher risk of their cancer returning who are not candidates for sur…
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope to hold back lung cancer after initial treatment
Disease control OngoingThis study is testing if a daily pill called osimertinib can help keep stage III lung cancer from growing or spreading in people who have a specific genetic change (EGFR mutation). It is for patients whose cancer has not gotten worse after completing standard chemoradiation treat…
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Scientists hunt for bacterial clues to personalize lung cancer care
Knowledge-focused OngoingThis study aims to learn if the collection of bacteria in a patient's body (the microbiome) can help predict who will benefit from a specific lung cancer immunotherapy drug called durvalumab, or who might experience severe side effects. Researchers will collect stool, throat swab…
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC
-
Blood test could predict lung cancer survival after treatment
Knowledge-focused OngoingThis study aims to learn if a simple blood test can help predict how well patients with a specific stage of lung cancer will do after treatment. It will observe 100 patients in Spain who have stage IIIA non-small cell lung cancer and are scheduled to receive treatment before surg…
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Sponsor: Fundación GECP • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:24 UTC